Journals / Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi / 2013 / Cilt: 5 - Sayı: 3

Gastrointestinal Hemorrhage due to Cefoperazone-sulbactam in Chronic Kidney Disease: Three Cases Report

Kronik Böbrek Hastalığında Sefoperazon-Sulbaktam kullanımına bağlı Gastrointestinal Kanama: Üç Olgu Sunumu

Pages
159–163
Publication Date
2013-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We suggest that in setting of long-term using of cefoperazone, patients should take a prophylactic supplement of K vitamin

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although third generation cephalosporins have widespectrum effect, its rare but severe side effect is bleeding.
📊
Key Findings & Data:All patients suffered from chronic kidney disease and combination of cefoperazone-sulbactam drugs had been administrated to all patients due to inflammation.
💡
Conclusion & Impact:We suggest that in setting of long-term using of cefoperazone, patients should take a prophylactic supplement of K vitamin
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:sefoperazon · kanama · kronik böbrek hastalığı

Abstract

Although third generation cephalosporins have widespectrum effect, its rare but severe side effect is bleeding. We present three cases that had hemorrhage. All patients suffered from chronic kidney disease and combination of cefoperazone-sulbactam drugs had been administrated to all patients due to inflammation. Active gastrointestinal bleeding developed in those patients after taking this combination therapy. In the setting of coagulopathy such as chronic kidney disease, cefoperazone may deteriorate carboxylation of vitamin K, leading to the tendency to bleeding due to hypoprothrombinemia. We suggest that in setting of long-term using of cefoperazone, patients should take a prophylactic supplement of K vitamin

Özet

Geniş spektrumlu klinikte sık kullanılan 3. kuşak sefalosporin grubunun nadir de olsa ciddi yan etkilerinden biri de kanamadır. Bu olgu sunumunda bilinen kronik böbrek hastalığı öyküsü olan, kliniğimizde farklı zamanlarda enfeksiyon nedeniyle sefoperazon-sulbaktam tedavisi başlanmasından ortalama bir hafta sonra aktif gastointestinal sistem kanaması gelişen üç vakayı sunduk. Kronik böbrek hastalığı gibi hipokoagülopatik hastalıklarda, sefoperazonun K vitamini bağımlı karboksilasyonu bozarak hipoprotrombinemiye bağlı kanamaya bir yatkınlık olduğu ve uzun süreli kullanımlarda proflaktik K vitamini desteği yapılması gerektiği kanaatindeyiz.

🔖

Cite This Article

ŞAHİN, Ş., TAŞLIYURT, T., DEMİRTAŞ, A., TAŞTAN, İ., BİLİR, Y. (2013). Gastrointestinal Hemorrhage due to Cefoperazone-sulbactam in Chronic Kidney Disease: Three Cases Report. Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi, Cilt: 5 - Sayı: 3, 159–163. https://ajindex.com/articles/831261

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...